Beranda084990 • KOSDAQ
add
Helixmith Co Ltd
Tutup sebelumnya
₩5.910,00
Rentang hari
₩5.690,00 - ₩6.050,00
Rentang tahun
₩2.115,00 - ₩8.940,00
Kapitalisasi pasar
270,56 M KRW
Volume Rata-Rata
466,69 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
KOSDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (KRW) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 564,70 jt | -68,68% |
Biaya operasional | 2,84 M | -51,10% |
Penghasilan bersih | -1,02 M | 73,20% |
Margin laba bersih | -180,11 | 14,42% |
Penghasilan per saham | — | — |
EBITDA | -2,27 M | 42,79% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (KRW) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 82,10 M | 16,53% |
Total aset | 144,42 M | -3,66% |
Total liabilitas | 5,85 M | -3,67% |
Total ekuitas | 138,57 M | — |
Saham yang beredar | 46,05 jt | — |
Harga terhadap nilai buku | 1,96 | — |
Tingkat pengembalian aset | -4,61% | — |
Tingkat pengembalian modal | -4,80% | — |
Arus Kas
Perubahan kas bersih
| (KRW) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -1,02 M | 73,20% |
Kas dari operasi | -1,00 M | 77,77% |
Kas dari investasi | -4,96 M | -115,51% |
Kas dari pembiayaan | -37,06 jt | -454,63% |
Perubahan kas bersih | -5,97 M | -121,48% |
Arus kas bebas | -224,30 jt | -142,86% |
Tentang
Helixmith Co. LTD. is a biotechnology company located in Seoul, South Korea with US presence in San Diego. The company has an extensive gene therapy pipeline, including a non-viral plasmid DNA program for neuromuscular and ischemic disease, a CAR-T program targeting several different types of solid tumors, and an AAV vector program targeting neuromuscular diseases. Helixmith’s lead gene is Engensis, currently in phase III diabetic peripheral neuropathy in the US. Engensis is a plasmid DNA designed to simultaneously express two isoforms of hepatocyte growth factor, HGF 728 and HGF 723. In addition to DPN, Engensis is also being studied in diabetic foot ulcers, amyotrophic lateral sclerosis, coronary artery disease, claudication, and Charcot-Marie-Tooth disease. Wikipedia
Didirikan
Nov 1996
Situs
Karyawan
38
